These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 16550749

  • 21. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting time.
    Pötzsch B, Madlener K, Seelig C, Riess CF, Greinacher A, Müller-Berghaus G.
    Thromb Haemost; 1997 May; 77(5):920-5. PubMed ID: 9184403
    [Abstract] [Full Text] [Related]

  • 22. R-hirudin as anticoagulant in regular hemodialysis therapy: finding of therapeutic R-hirudin blood/plasma concentrations and respective dosages.
    Bucha E, Nowak G, Czerwinski R, Thieler H.
    Clin Appl Thromb Hemost; 1999 Jul; 5(3):164-70. PubMed ID: 10726003
    [Abstract] [Full Text] [Related]

  • 23. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
    Devignes J, de Maistre E, Grosjean S, Walter AF, Hacquard M, Mulot A, Longrois D, Carteaux JP, Lecompte T.
    Ann Biol Clin (Paris); 2005 Jul; 63(2):201-8. PubMed ID: 15771978
    [Abstract] [Full Text] [Related]

  • 24. Pharmacodynamics and pharmacokinetics of polyethylene glycol-hirudin in patients with chronic renal failure.
    Pöschel KA, Bucha E, Esslinger HU, Nörtersheuser P, Jansa U, Schindler S, Nowak G, Stein G.
    Kidney Int; 2000 Dec; 58(6):2478-84. PubMed ID: 11115081
    [Abstract] [Full Text] [Related]

  • 25. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study.
    Dietrich W, Dilthey G, Spannagl M, Jochum M, Braun SL, Richter JA.
    Anesthesiology; 1995 Oct; 83(4):679-89; discussion 29A-30A. PubMed ID: 7574046
    [Abstract] [Full Text] [Related]

  • 26. Low molecular weight heparin (CY-216) versus unfractionated heparin in chronic hemodialysis.
    Grau E, Sigüenza F, Maduell F, Linares M, Olaso MA, Martinez R, Caridad A.
    Nephron; 1992 Oct; 62(1):13-7. PubMed ID: 1331831
    [Abstract] [Full Text] [Related]

  • 27. A comparison between the use of recombinant hirudin and heparin during hemodialysis.
    van Wyk V, Badenhorst PN, Luus HG, Kotzé HF.
    Kidney Int; 1995 Oct; 48(4):1338-43. PubMed ID: 8569097
    [Abstract] [Full Text] [Related]

  • 28. Profile of low molecular weight tinzaparin sodium for anticoagulation during hemodialysis.
    Al-Saran KA, Sabry A, Taha M, Ghafour MA, Al Fawzan F.
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):43-9. PubMed ID: 20061691
    [Abstract] [Full Text] [Related]

  • 29. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
    Ireland HA, Boisclair MD, Lane DA, Thompson E, Curtis JR.
    Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
    [Abstract] [Full Text] [Related]

  • 30. Plasma hypercoagulability in haemodialysis patients: impact of dialysis and anticoagulation.
    Ambühl PM, Wüthrich RP, Korte W, Schmid L, Krapf R.
    Nephrol Dial Transplant; 1997 Nov; 12(11):2355-64. PubMed ID: 9394323
    [Abstract] [Full Text] [Related]

  • 31. Different effects of enoxaparin and unfractionated heparin on some thrombogenesis markers during hemodialysis: a cross-over study.
    Naumnik B, Pawlak K, Myśliwiec M.
    Thromb Res; 2009 Feb; 123(4):631-6. PubMed ID: 18234290
    [Abstract] [Full Text] [Related]

  • 32. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D, Långström S, Petäjä J, Heikinheimo M, Pihkala J.
    Catheter Cardiovasc Interv; 2013 Jun 01; 81(7):1174-9. PubMed ID: 22915548
    [Abstract] [Full Text] [Related]

  • 33. Unfractionated heparin but not enoxaparin causes delayed plasma PAI-1 depletion in hemodialysis patients: a prospective study.
    Naumnik B, Pawlak K, Mys'liwiec M.
    Clin Appl Thromb Hemost; 2009 Feb 01; 15(1):84-91. PubMed ID: 17895513
    [Abstract] [Full Text] [Related]

  • 34. A quick assay for monitoring recombinant hirudin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II : adaptation of the ecarin clotting time to the act II device.
    Koster A, Loebe M, Hansen R, Bauer M, Mertzlufft F, Kuppe H, Hetzer R.
    J Thorac Cardiovasc Surg; 2000 Jun 01; 119(6):1278-83. PubMed ID: 10838548
    [Abstract] [Full Text] [Related]

  • 35. The effect of r-hirudin vs. heparin on blood-membrane interactions during hemodialysis.
    van Wyk V, Badenhorst PN, Kotzé HF.
    Clin Nephrol; 1997 Dec 01; 48(6):381-7. PubMed ID: 9438098
    [Abstract] [Full Text] [Related]

  • 36. Comparison of effects of different heparins on thrombin activatable fibrinolysis inhibitor in hemodialyzed patients.
    Małyszko J, Małyszko JS, Hryszko T, Pawlak K, Myśliwiec M.
    Am J Nephrol; 2004 Dec 01; 24(6):624-9. PubMed ID: 15627717
    [Abstract] [Full Text] [Related]

  • 37. Hemodialysis with a dialyzer loaded with argatroban may be performed in vivo without a systemic anticoagulant.
    Zhang Y, Ning J, Veeraragoo P, Li Y, Dai S.
    Blood Purif; 2012 Dec 01; 33(4):300-6. PubMed ID: 22652560
    [Abstract] [Full Text] [Related]

  • 38. A heparin-coated dialysis filter (AN69 ST) does not reduce clotting during hemodialysis when compared to a conventional polysulfone filter (F×8).
    Sagedal S, Witczak BJ, Osnes K, Hartmann A, Os I, Eikvar L, Klingenberg O, Brosstad F.
    Blood Purif; 2011 Dec 01; 32(3):151-5. PubMed ID: 21659742
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
    Sánchez-Canel JJ, Pons-Prades R, Salvetti ML, Seores A, Vázquez M, Pérez-Alba A, Tamarit E, Calvo-Gordo C, Villatoro J.
    Nefrologia; 2012 Dec 01; 32(5):605-12. PubMed ID: 23013946
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
    Vanholder R, Camez A, Veys N, Van Loo A, Dhondt AM, Ringoir S.
    Thromb Haemost; 1997 Apr 01; 77(4):650-5. PubMed ID: 9134637
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.